We propose that the pseudomonal-specific Th22 cells we have identified in healthy humans and patients with CF can migrate to inflamed lung, which will release the chemokines CCL20 and β-defensins, both ligands for CCR6. This evidence concerns the gene CCR6 and cystic fibrosis.